"As a reward and encouragement to the people of Holguín" the surgical-clinical Hospital Lucía Íñiguez Landín of this eastern province (HQCLIL) began to provide services 24 years ago, which celebrated the date on November 28.

Scientists from the Center for Genetic Engineering and Biotechnology (CIGB) together with researchers from the Cuban health system have been developing for a decade a promising vaccine candidate HeberSaVax to guarantee the survival of patients with liver cancer or hepatocarcinoma, a pathology that annually causes more than half a million deaths worldwide.

The three provincial hospitals in Holguín will have, once installed, five medical oxygen plants that began entering the territory last week as part of a donation from the People's Republic of China.

The research takes place within the collaboration framework between the Center for Molecular Immunology of Cuba and the Roswell Park Center of the United States.